Immunomet Therapeutics, Inc. — Form D

Immunomet Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-05. The offering totals $10.0M, of which $842K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-02-05
• Form: D
• Accession: 0002109829-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $842K
• Remaining: $9.2M
• Investors: 4
• Date of first sale: 2026-01-21
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-572548

Issuer

• Name: Immunomet Therapeutics, Inc.
• CIK: 0002109829
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2450 HOLCOMBE BLVD., HOUSTON, TX, 77021
• Phone: 346-772-0318

Officers, directors & promoters (2)

More

• CIK 2109829 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search